3600 

Anti-Intrinsic 

Factor 

quantitative determination of IgG autoantibodies to 

intrinsic factor in human serum  

[microtiter plate coated with intrinsic factor] 

96 (89 + C) 

105 min /  

100 µl of 1:100 dil. 

3610 

Anti-GPC 

quantitative determination of IgG autoantibodies to 

gastric parietal cells in human serum  

[microtiter plate coated with H+/K+-ATPase (α- und β 

subunit)] 

96 (89 + C) 

105 min /  

100 µl of 1:100 dil. 

3710 

GliaDea IgA 

quantitative determination of IgA antibodies to 

deamidated gliadin in human serum  

[microtiter plate coated with deamidated gliadin] 

96 (89 + C) 

105 min /  

100 µl of 1:100 dil. 

3750 

Anti-GP2 

IgA 

quantitative determination of IgA antibodies to 

glycoprotein 2 (GP2) in human serum  

[microtiter plate coated with GP2] 

96 (89 + C) 

105 min /  

100 µl of 1:100 dil. 

3810 

GliaDea IgG 

quantitative determination of IgG antibodies to 

deamidated gliadin in human serum 

[microtiter plate coated with deamidated gliadin] 

96 (89 + C) 

105 min /  

100 µl of 1:100 dil. 

3850 

Anti-GP2 

IgG 

quantitative determination of IgG antibodies to 

glycoprotein 2 (GP2) in human serum 

[microtiter plate coated with GP2] 

96 (89 + C) 

105 min /  

100 µl of 1:100 dil. 

3950

 Pancreatitis 

GP2 

quantitative determination of glycoprotein 2 (GP2) in 

human serum [microtiter plate coated with anti-GP2] 

96 (90 + C) 

105 min / 100 µl  

4006 

ASCA IgA 

quantitative and qualitative determination of IgA 

antibodies to Saccharomyces cerevisiae, mannan 

(ASCA) in human serum [microtiter plate coated with 

mannan of Saccharomyces cerevisiae] 

96 (89 + C) 

105 min /  

100 µl of 1:100 dil. 

4007 

ASCA IgG 

quantitative and qualitative determination of IgG 

antibodies to Saccharomyces cerevisiae, mannan 

(ASCA) in human serum [microtiter plate coated with 

mannan of Saccharomyces cerevisiae] 

96 (89 + C) 

105 min /  

100 µl of 1:100 dil. 

4033 

Anti-

huTransG 

quantitative determination of IgA autoantibodies to 

tissue transglutaminase in human serum [microtiter plate 

coated with tissue transglutaminase and gliadin traces] 

96 (89 + C) 

105 min /  

100 µl of 1:100 dil. 

4035 

CeliAK EmA 

human 

quantitative determination of IgA autoantibodies to 

human endomysial autoantigens (EmA)  

[microtiter plate coated with purified human EmA 

autoantigen and gliadin fragments] 

96 (89 + C) 

105 min /  

100 µl of 1:100 dil. 

4044 

Anti-hu tTG 

IgG 

quantitative determination of IgG autoantibodies to 

tissue transglutaminase in human serum [microtiter plate 

coated with tissue transglutaminase and gliadin traces] 

96 (89 + C) 

105 min /  

100 µl of 1:100 dil. 

4045

 CeliAK EmA 

human IgG 

quantitative determination of IgG autoantibodies to 

human endomysial autoantigens (EmA)  

[microtiter plate coated with purified human EmA 

autoantigen and gliadin fragments] 

96 (89 + C) 

105 min /  

100 µl of 1:100 dil. 

6012 

6013 

Helicobacter 

pylori 

Antigen 

qualitative determination of Helicobacter pylori antigen in 

fecal samples 

[MTP coated with anti-Helicobacter pylori antibodies] 

48 (45 + C) /  

96 (93 + C) 

3900 

Anti-

ASGPR 

semi-quantitative determination of IgG antibodies to 

asialoglycoprotein receptor in human serum or plasma 

[microtiter plate coated with ASGPR] 

96 (93 + C) 

105 min / 100 µl  

of 1:100 dil. 

4052

 Anti-M2 

quantitative determination of IgG antibodies to the 

mitochondrial antigen M2 in human serum or plasma 

[microtiter plate coated with M2 antigen (PDC-E2, 

OGDC-E2, and BCOADC-E2)] 

96 (89 + C) 

105 min / 100 µl  

of 1:100 dil. 

4053

 Anti-LKM-1 

quantitative determination of IgG antibodies to 

cytochrome p450 IID6 in human serum or plasma 

[microtiter plate coated with LKM-1 (cytochrome P450 

IID6)] 

96 (89 + C) 

105 min / 100 µl  

of 1:100 dil. 

3920 

GA CoV-2 

IgG 

semi-quantitative determination of IgG antibodies to 

SARS-Coronavirus 2 (SARS-CoV-2) in human serum and 

plasma [microtiter plate coated with Spike and 

Nucleocapsid antigens of SARS-CoV-2 (recombinant)] 

96 (91 + C) 

105 min / 10 µl 

3930 

GA CoV-2 

IgM 

semi-quantitative determination of IgM antibodies to 

SARS-Coronavirus 2 (SARS-CoV-2) in human serum and 

plasma [microtiter plate coated with Spike and 

Nucleocapsid antigens of SARS-CoV-2 (recombinant)] 

96 (91 + C) 

105 min / 200 µl  

of 1:40 dil. 

3940

 GA CoV-2 

IgG + 

semi-quantitative determination of the IgG antibodies 

specificity to immunodominant antigens of SARS-CoV-2 in 

human serum and plasma previously tested positive for 

IgG antibodies [microtiter plate coated separately with 

Spike Glycoprotein 1, Spike Glycoprotein 2 and 

Nucleocapsid antigens of SARS-CoV-2 (recombinant)] 

24 x 4 (22 + C) 

105 min / 200 µl  

of 1:20 dil. 

4067 

Anti-Faktor H 

quantitative determination of IgG antibodies to 

complement factor H in human serum 

[microtiter plate coated with complement factor H] 

48 (41 + C) 

105 min /  

100 µl of 1:100 dil. 

4014 

Anti-

Cardiolipin 

Screen 

semi-quantitative determination of IgG, IgM and IgA 

antibodies (screening) to cardiolipin in human serum or 

plasma 

[microtiter plate coated with cardiolipin and  

β2 GP I] 

96 (93 + C) 

105 min / 100 µl 

of 1:100 dil. 

4016 

Anti-

Cardiolipin 

quantitative determination of IgG or IgM antibodies to 

cardiolipin in human serum or plasma  

[microtiter plate coated with cardiolipin and β2 GP I] 

96 (89 + C) 

105 min / 100 µl 

of 1:100 dil. 

4036 

Anti-β2 GP-I 

Screen 

semi-quantitative determination of IgG, IgM and IgA 

antibodies (screening) to β2 glycoprotein-I (β2 GP-I) in 

human serum or plasma  

[microtiter plate coated with β2 glycoprotein-I] 

96 (93 + C) 

105 min / 100 µl 

of 1:100 dil. 

4041 

Anti-β2 GP-I 

quantitative determination of IgG or IgM antibodies to β2 

glycoprotein-I (β2 GP-I) in human serum or plasma 

[microtiter plate coated with β2 glycoprotein-I] 

96 (89 + C) 

105 min / 100 µl 

 of 1:100 dil. 

4050 

Anti-

Phospholipid 

screen 

quantitative determination of IgG or IgM antibodies to 

phospholipids (cardiolipin, phosphatidyl-serine, -inositol, -

ethanolamine, phosphatidic acid) in human serum or 

plasma [microtiter plate coated with β2 GP I, cardiolipin, 

phosphatidyl-serine, -inositol, -ethanolamine and 

phosphatidic acid] 

96 (89 + C) 

105 min / 100 µl 

of 1:100 dil. 

4056 

Anti-

Phosphatidyl

-Serin 

quantitative determination of IgG or IgM antibodies to 

phosphatidylserine in human serum or plasma [microtiter 

plate coated with phosphatidylserine and β2 glycoprotein] 

96 (89 + C) 

105 min / 100 µl  

of 1:100 dil. 

4010

 ANAscreen 

semi-quantitative simultaneous determination of 

autoantibodies to 8 nuclear and cytoplasmic antigens in 

human serum or plasma  

[microtiter plate with HeLa cell nuclei and nuclear 

antigens] 

96 (93 + C) 

105 min /  

100 µl of 1:100 dil. 

4012 

ANApro 

semi-quantitative separate determination of 

autoantibodies to nuclear and cytoplasmic antigens in 

human serum or plasma  

[microtiter plate coated with ds-DNA, RNP (68kDa, A, C), 

Sm, SS-A (60kDa), SS-B, Scl-70, CENP-B, Jo-1] 

12 x 8 (10 + C) 

105 min /  

100 µl of 1:100 dil. 

4027

 RF IgA 

quantitative determination of IgA antibodies to rheumatoid 

factor (RF) in Fc region of IgG in human serum or plasma 

[microtiter plate coated with rabbit IgG] 

96 (89 + C) 

105 min /  

100 µl of 1:100 dil. 

4085

 RF IgG 

quantitative determination of IgG antibodies to rheumatoid 

factor (RF) in Fc region of IgG in human serum or plasma 

[microtiter plate coated with rabbit IgG] 

96 (89 + C) 

105 min /  

100 µl of 1:100 dil. 

4046 

RF IgM 

quantitative determination of rheumatoid factor (RF) IgM 

antibodies to Fc region of IgG in human serum or plasma 

[microtiter plate coated with rabbit IgG] 

96 (89 + C) 

105 min /  

100 µl of 1:100 dil. 

4015 

Anti-dsDNA 

qualitative and quantitative determination of IgG antibodies 

to double-stranded deoxyribonucleic acid (dsDNA) in 

human serum or plasma  

[microtiter plate coated with dsDNA] 

96 (89 + C) 

105 min /  

100 µl of 1:100 dil. 

4058 

Anti-MPO 

qualitative and quantitative determination of IgG 

autoantibodies to myeloperoxidase (MPO) in human serum 

[microtiter plate coated myeloperoxidase (MPO)] 

96 (89 + C) 

105 min /  

100 µl of 1:100 dil. 

4259 

Anti-PR3 hs 

qualitative and quantitative determination of IgG 

autoantibodies to proteinase 3 (PR3) in human serum 

[microtiter plate coated with proteinase 3 (PR3)] 

96 (89 + C) 

105 min / 

100 µl of 1:100 dil.